Next, we used human glioblastoma U87-MG cells because treatment with the alkylating chemotherapeutic agent temozolomide (TMZ) provokes cellular stress to induce p38 activation as well as the migratory ability (25). This evidence concerns the gene MAPK1 and glioblastoma.